OK, but aren't you taking it along with inflectra?
The dosing I gave was for monotherapy with aza, not for combo therapy with an anti-tnf.
For combo therapy, the dosing recommendation is ... actually still the same, at least for now.
There is thought that lower doses might be sufficient when it's taken along with an anti-tnf. It's unknown what doses are needed for prevention of anti-tnf antibody formation. It might be less than the guidelines I gave above, or it might not. I'm pretty sure there are studies/trials looking into that right now.